Basal Cell Carcinoma Treatment Size, Share and Forecast (2019-2026)

(PharmaNewsWire.Com, August 30, 2019 ) Market Overview

Basal cell carcinoma (BCC) is a type of skin cancer which begins in the basal cell, a cell within the skin that produces new skin cells as old ones die off.

Basal cell carcinoma occurs mostly in areas of the skin that are exposed to the sun, such as the head and neck.

Growth and Trends

Primary market drivers include increased incidence of basal cell carcinoma globally as it is one of the most common forms of skin cancer.

BCC is more common in white-skinned individuals.

Also, environmental factors leading to more significant exposure to UV radiation also drive market growth.

However, side effects associated with the treatment and long approval time for the drugs may hamper the growth of the market.

Market Size and Segmentation

• The global Basal Cell Carcinoma Treatment market report segments the market by treatment type, by end-user, and by region.

• Based on the treatment type, the market is classified into surgical techniques, drugs, and others.

• Surgical techniques further include excisional surgery,

• non-melanoma skin cancer

• squamous cell carcinoma

• electrodesiccation & cutterage, Moh’s micrographic surgery, and cryosurgery.

• The drugs segment is sub-segmented into topical medications and oral medicines.

• The other segment is sub-segmented into radiation therapy, photodynamic therapy, and laser therapy.

• Surgical treatments for Basal Cell Carcinoma are likely to remain more in demand over the forecast period.

• By end-user, the market is segmented into hospitals, specialty clinics, and others.

View full report: https://www.datamintelligence.com/research-report/basal-cell-carcinoma-treatment-market

Key Players

Pharmaceuticals International, Inc.,

• Sun Pharmaceuticals Ltd.

• F. Hoffmann-La Roche Ltd.

• Mylan N.V.

• Merck & Co., Inc.

• Others

By Treatment Type

• Surgical Techniques

• Drugs

• non-melanoma skin cancer

• squamous cell carcinoma

• Others

By End-User

• Hospitals

• Specialty Clinics

• Cancer Research Institutes

Geographical Share

• North America

• Europe

• South America

• Asia Pacific

• The Middle East and Africa

Download free sample: https://www.datamintelligence.com/download-sample/basal-cell-carcinoma-treatment-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at Data M Intelligence

Email: info@datamintelligence.com

Tel: +1 877 441 4866

Website: www.datamintelligence.com

DataM Intelligence

Sai Kiran

+1 877 441 4866

pr@datamintelligence.com

Source: EmailWire.Com

Source: EmailWire.com

Pharmaceutical News!

Basal Cell Carcinoma Treatment Size, Share and Forecast (2019-2026)